New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
INmune Bio, Inc.
INMB
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

59M

Biotechnology

Next Earning date - 07 Aug 2025

59M

Biotechnology

Next Earning date - 07 Aug 2025

2.53USD

Shape0.17 ( 7.20%)
Market Closed (as of Jul 03, 20:00 EDT)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

107%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

78%

Quote Panel

Shape
Updated July 5, 2025
1W 9.52 % 1M -66.80 % 3M -65.34 % 1Y -67.10 %

Key Metrics

Shape
  • Market Cap

    58.72M


  • Shares Outstanding

    23.21M


  • Share in Float

    16.50M


  • Dividende

    0


  • Earning Date

    07 Aug 2025


  • Price Target

    2.53


  • Average Volume

    2.27M


  • Beta

    1.567


  • Range

    1.89-11.64


  • Industry

    Biotechnology


  • Website

    https://www.inmunebio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

INMB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape8555%

2026-Revenue

$1.69

Shape-293%

2026-EPS

$4M

Shape56%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Raymond James

initialise

Previous: Not converted

2024-09-26

Now: Outperform

Scotiabank

initialise

Previous: Not converted

2024-08-21

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-0.36
vs -0.38

Q3.23

arrow
arrow

N/A

-0.48
vs -0.43

Q4.23

arrow
arrow

N/A

-0.47
vs -0.32

Q1.24

arrow
arrow

N/A

-0.61
vs -0.36

Q2.24

arrow
arrow

N/A

-0.50
vs -0.36

Q3.24

arrow
arrow

N/A

-0.60
vs -0.48

Q4.24

arrow
arrow

N/A

-0.40
vs -0.47

Q1.25

arrow
arrow

N/A

-0.43
vs -0.61

Q2.25

arrow
arrow

N/A

-0.43
vs -0.50

Q3.25

arrow
arrow

N/A

-0.40
vs -0.60

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

+188%

46K  vs 16K

Q3.23

arrow
arrow

-56%

43K  vs 98K

Q4.23

arrow
arrow

-71%

28K  vs 97K

Q1.24

arrow
arrow

-63%

14K  vs 38K

Q2.24

arrow
arrow

-100%

NA  vs 46K

Q3.24

arrow
arrow

-100%

NA  vs 43K

Q4.24

arrow
arrow

-100%

NA  vs 28K

Q1.25

arrow
arrow

+257%

50K  vs 14K

Q2.25

arrow
arrow

NA

3K  vs NA

Q3.25

arrow
arrow

NA

3.1K  vs NA

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

-13%

-0.13
vs -0.12

Q3.23

arrow
arrow

-19%

-0.19
vs -0.13

Q4.23

arrow
arrow

-22%

-0.22
vs -0.19

Q1.24

arrow
arrow

-38%

-0.38
vs -0.22

Q2.24

arrow
arrow

-26%

-0.26
vs -0.38

Q3.24

arrow
arrow

-31%

-0.31
vs -0.26

Q4.24

arrow
arrow

-29%

-0.29
vs -0.31

Q1.25

arrow
arrow

-33%

-0.33
vs -0.29

Institutionnal OwnershipShape

status-upQoQ

Q2.23

arrow
arrow

37

37
vs 35

6%

Q3.23

arrow
arrow

41

41
vs 37

11%

Q4.23

arrow
arrow

52

52
vs 41

27%

Q1.24

arrow
arrow

54

54
vs 52

4%

Q2.24

arrow
arrow

60

60
vs 54

11%

Q3.24

arrow
arrow

68

68
vs 60

13%

Q4.24

arrow
arrow

75

75
vs 68

10%

Q1.25

arrow
arrow

86

86
vs 75

15%

Earnings Growth

Latest News